Concepedia

Joseph Sgouros

JS

Statistics

Publications

21

Citations

989

H-Index

15

Active since

2002

Affiliations

Hospital Agioi Anargyroi(Current)

Metropolitan Hospital

Aristotle University of Thessaloniki

Papageorgiou General Hospital

University Hospital of Ioannina

Joseph Sgouros is an author at Hospital Agioi Anargyroi specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

2002–2021

21

Publications

21

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

Anthony Maraveyas, Justin S. Waters, Rajarshi Roy et al. · European Journal of Cancer · 2011 · 316 citations · Full text

, , +14

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

George Pentheroudakis, Vassiliki Kotoula, Wendy De Roock et al. · BMC Cancer · 2013 · 111 citations · Full text

, , +17

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

Dimitrios Pectasides, George Papaxoinis, Konstantine T. Kalogeras et al. · BMC Cancer · 2012 · 76 citations · Full text

, , +13

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

Anna G. Antonacopoulou, Anastasia G Eleftheraki, Anna Koumarianou et al. · The Pharmacogenomics Journal · 2011 · 75 citations

, , +17

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer

Dimitrios Pectasides, Vasilios Karavasilis, George Papaxoinis et al. · BMC Cancer · 2015 · 51 citations · Full text

, , +15

1–5 of 21